Long-term clinical experience with zofenopril.

Item

http://www.wikidata.org/entity/Q38048833

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Long-term clinical experience with zofenopril.

@en

type

Item

label

Long-term clinical experience with zofenopril.

@en

prefLabel

Long-term clinical experience with zofenopril.

@en

P1476

Long-term clinical experience with zofenopril.

@en

P2093

Claudio Borghi

http://www.w3.org/2001/XMLSchema#string

Daniela Degli Esposti

http://www.w3.org/2001/XMLSchema#string

Stefano Bacchelli

http://www.w3.org/2001/XMLSchema#string

P2860

Does aspirin reduce the benefit of an angiotensin-converting enzyme inhibitor? Choosing between the Scylla of observational studies and the Charybdis of subgroup analysis

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-conve

The renin-angiotensin system in the twenty-first century.

Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors.

Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial.

Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.

P304

973-982

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERC.12.81

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231816562

http://www.w3.org/2001/XMLSchema#string

P698

23030285

http://www.w3.org/2001/XMLSchema#string

P921

zofenopril